{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:38:45Z","timestamp":1792604325784,"version":"4.5.0"},"publisher-location":"Cham","reference-count":106,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032294364","type":"print"},{"value":"9783032294371","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-29437-1_24","type":"book-chapter","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:53:34Z","timestamp":1792601614000},"page":"377-395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analytical Insights into Biologically Active Substances Using Mass Spectrometric Techniques"],"prefix":"10.1007","author":[{"given":"Mihaela","family":"Silion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca-Roxana","family":"Petrovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana-Mirela","family":"Vasincu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenuta","family":"Profire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Apreotesei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Simionescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Pinteala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2027,1,23]]},"reference":[{"key":"24_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-76859-0_1","volume-title":"Biotechnological Intervention in Production of Bioactive Compounds. Sustainable Landscape Planning and Natural Resources Management","author":"E Sandhya Rani","year":"2025","unstructured":"Sandhya Rani E, Sravya B, Sowmika S, Golla N (2025) Exploring bioactive compounds: biosynthesis, extraction, characterization, and diverse applications\u2014an overview. In: Devi J (Ed.) Biotechnological Intervention in Production of Bioactive Compounds. Sustainable Landscape Planning and Natural Resources Management. Springer, Cham, https:\/\/doi.org\/10.1007\/978-3-031-76859-0_1"},{"key":"24_CR2","doi-asserted-by":"crossref","unstructured":"Szajdak LW 2016 Introduction: biologically active compounds. In: Bioactive compounds in agricultural soils. Springer International Publishing, pp 1\u201322","DOI":"10.1007\/978-3-319-43107-9_1"},{"key":"24_CR3","doi-asserted-by":"publisher","unstructured":"Bulut S, Toslak R, Muhammed MT et al (2025) Antioxidant, antidiabetic, and antiobesity properties of Stachys cretica subsp. anatolica and its LC\u2013MS\/MS analysis: in vitro and in silico studies. Chem Biodivers 22(12):e02336. https:\/\/doi.org\/10.1002\/cbdv.202502336","DOI":"10.1002\/cbdv.202502336"},{"issue":"1","key":"24_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/ansa.70024","volume":"6","author":"S Alanazi","year":"2025","unstructured":"Alanazi S (2025) Recent advances in liquid chromatography\u2013mass spectrometry (LC\u2013MS) applications in biological and applied sciences. Anal Sci Adv 6(1), e70024.","journal-title":"Anal Sci Adv"},{"key":"24_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-99178-3","volume":"15","author":"MA Awad","year":"2025","unstructured":"Awad MA, Soliman HSM, El-Mashtoly SF, et al. (2025) Isolation and characterization of a bioactive compound from Sphingomonas sanguinis DM with cytotoxic and molecular docking analysis. Sci Rep 15, 16049. https:\/\/doi.org\/10.1038\/s41598-025-99178-3","journal-title":"Sci Rep"},{"issue":"4","key":"24_CR6","first-page":"316","volume":"7","author":"R Bonfilio","year":"2010","unstructured":"Bonfilio R, de Ara\u00fajo MB, Salgado HRN (2010) Recent applications of analytical techniques for quantitative pharmaceutical analysis: a review. WSEAS Trans Biol Biomed 7(4):316\u2013338.","journal-title":"WSEAS Trans Biol Biomed"},{"key":"24_CR7","doi-asserted-by":"publisher","unstructured":"Shen J, Wei J, Li L et al (2018) Development of a HPLC-MS\/MS method to determine 11 bioactive compounds in tongmai yangxin pill and application to a pharmacokinetic study in rats. Evid Based Complementary Alternat Med 2018:6460393 https:\/\/doi.org\/10.1155\/2018\/6460393","DOI":"10.1155\/2018\/6460393"},{"key":"24_CR8","doi-asserted-by":"crossref","unstructured":"Wormwood KL, Deng L, Hamid AM et al (2019) The potential for ion mobility in pharmaceutical and clinical analyses. Adv Exp Med Biol 1140:299\u2013316","DOI":"10.1007\/978-3-030-15950-4_17"},{"key":"24_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/978-3-030-15950-4_25","volume":"1140","author":"MR Robinson","year":"2019","unstructured":"Robinson MR, Miller RA, Spellman DS (2019) Mass spectrometry-based biomarkers in drug development. Adv Exp Med Biol 1140:435\u2013449.","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"24_CR10","first-page":"a574","volume":"8","author":"SB Ombase","year":"2023","unstructured":"Ombase SB, Pandhare RB, Nagrale KD, et al. (2023) Applications of MS in pharmaceutical analysis: a review. Int J Novel Res Devel 8(8):a574\u2013a584. https:\/\/ijnrd.org\/papers\/IJNRD2308068.pdf","journal-title":"Int J Novel Res Devel"},{"issue":"1","key":"24_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2211185","volume":"15","author":"J Zarzar","year":"2023","unstructured":"Zarzar J, Khan T, Bhagawati M, et al. (2023) High concentration formulation developability approaches and considerations. MAbs 15(1), 2211185. https:\/\/doi.org\/10.1080\/19420862.2023.2211185","journal-title":"MAbs"},{"key":"24_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/bmc.3314","volume":"29","author":"X Zhang","year":"2015","unstructured":"Zhang X, Wang X, Vernikovskaya DI et al. (2015) Quantitative determination of metformin, glyburide and its metabolites in plasma and urine of pregnant patients by LC-MS\/MS. Biomed Chromatogr 29:560\u2013569. https:\/\/doi.org\/10.1002\/bmc.3314","journal-title":"Biomed Chromatogr"},{"issue":"2-3","key":"24_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/s0731-7085(00)00333-2","volume":"23","author":"EM Sheldon","year":"2000","unstructured":"Sheldon EM, Downar JB (2000) Development and validation of a single robust HPLC method for the characterization of a pharmaceutical starting material and impurities from three suppliers using three separate synthetic routes. J Pharm Biomed Anal 23(2-3):561\u2013572. https:\/\/doi.org\/10.1016\/s0731-7085(00)00333-2","journal-title":"J Pharm Biomed Anal"},{"key":"24_CR14","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/bmc.3309","volume":"28","author":"S Ravindran","year":"2014","unstructured":"Ravindran S, Jadhav A, Surve P et al. (2014) Technologies and strategies to characterize and quantitate metabolites in drug discovery and development. Biomed Chromatogr 28:1547\u20131553","journal-title":"Biomed Chromatogr"},{"key":"24_CR15","doi-asserted-by":"crossref","unstructured":"Liu Y, Romijn EP, Verniest G, et al (2019) Mass spectrometry-based structure elucidation of small molecule impurities and degradation products in pharmaceutical development. TrAC - Trends Anal Chem 121:115686","DOI":"10.1016\/j.trac.2019.115686"},{"key":"24_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-62703-342-8_6","volume":"993","author":"R Guha","year":"2013","unstructured":"Guha R (2013) On exploring structure-activity relationships. Methods Mol Biol 993:81\u201394. https:\/\/doi.org\/10.1007\/978-1-62703-342-8_6","journal-title":"Methods Mol Biol"},{"key":"24_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/kin.21172","volume":"50","author":"L Vereecken","year":"2018","unstructured":"Vereecken L, Aumont B, Barnes I et al. (2018) perspective on mechanism development and structure-activity relationships for gas-phase atmospheric chemistry. Int J Chem Kinet 50:435\u2013469. https:\/\/doi.org\/10.1002\/kin.21172","journal-title":"Int J Chem Kinet"},{"key":"24_CR18","doi-asserted-by":"crossref","unstructured":"Zimmet P, Alberti KG, Magliano DJ, Bennett PH (2016) Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol 12(10):616\u2013622","DOI":"10.1038\/nrendo.2016.105"},{"key":"24_CR19","doi-asserted-by":"publisher","unstructured":"Banday MZ, Sameer AS, Nissar S (2020) Pathophysiology of diabetes: an overview. Avicenna J Med 10:(4):174\u2013188. https:\/\/doi.org\/10.4103\/ajm.ajm_53_20","DOI":"10.4103\/ajm.ajm_53_20"},{"key":"24_CR20","doi-asserted-by":"publisher","unstructured":"Sinha P, Ubaidulla U, Nayak AK (2015) Okra (Hibiscus esculentus) gum-alginate blend mucoadhesive beads for controlled glibenclamide release. Int J Biol Macromol 72:1069\u20131075. https:\/\/doi.org\/10.1016\/j.ijbiomac.2014.10.002","DOI":"10.1016\/j.ijbiomac.2014.10.002"},{"key":"24_CR21","doi-asserted-by":"publisher","unstructured":"Cai M, Li Y, Guo M, et al (2025) Multifaceted safety concerns of glibenclamide in managing type 2 diabetes: evidence from real-world adverse event analysis. Eur J Pharmacol 1005:178113. https:\/\/doi.org\/10.1016\/j.ejphar.2025.178113","DOI":"10.1016\/j.ejphar.2025.178113"},{"key":"24_CR22","doi-asserted-by":"publisher","unstructured":"Kim NC, Graf TN, Sparacino CM, et al (2003) Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum). Org Biomol Chem 1:(10): 1684\u20131689. https:\/\/doi.org\/10.1039\/b300099k","DOI":"10.1039\/b300099k"},{"key":"24_CR23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/ptr.5768","volume":"31","author":"AM Stolf","year":"2017","unstructured":"Stolf AM, Cardoso CC, Acco A (2017) Effects of silymarin on diabetes mellitus complications: a review. Phytother Res 31:366\u2013374","journal-title":"Phytother Res"},{"key":"24_CR24","doi-asserted-by":"publisher","unstructured":"Jiang Y, Zhang XQ, Xu ZR (2004) Analysis of zoledronic acid and its related substances by ion-pair RP-LC. Chromatographia 60:(7):405\u2013409. https:\/\/doi.org\/10.1365\/s10337-004-0384-8","DOI":"10.1365\/s10337-004-0384-8"},{"key":"24_CR25","doi-asserted-by":"publisher","unstructured":"Vadhan-Raj S, Von Moos R, Fallowfield LJ et al (2012) Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid. Annals of Oncology 23:(12):3045\u20133051.\u2002https:\/\/doi.org\/10.1093\/annonc\/mds175","DOI":"10.1093\/annonc\/mds175"},{"key":"24_CR26","doi-asserted-by":"publisher","unstructured":"Oliveira AL, Pedro AJ, Saiz Arroyo C et al (2010) Biomimetic Ca-P coatings incorporating bisphosphonates produced on starch-based degradable biomaterials. J Biomed Mater Res B Appl Biomater 92:(1):55\u201367. https:\/\/doi.org\/10.1002\/jbm.b.31489","DOI":"10.1002\/jbm.b.31489"},{"key":"24_CR27","doi-asserted-by":"publisher","unstructured":"Petrovici AR, Silion M, Simionescu N et al (2022) Quantification of low amounts of zoledronic acid by HPLC-ESI-MS analysis: method development and validation. Int J Mol Sci 23:(11):5944. https:\/\/doi.org\/10.3390\/ijms23115944","DOI":"10.3390\/ijms23115944"},{"key":"24_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom11030361","volume":"11","author":"GM Miranda","year":"2021","unstructured":"Miranda GM, Ramos E, Santos VO, Bessa JR et al. (2021) Inclusion complexes of non-steroidal anti-inflammatory drugs with cyclodextrins: a systematic review. Biomolecules 11:1\u201324","journal-title":"Biomolecules"},{"key":"24_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5152\/eurasianjmed.2018.0010","volume":"50","author":"C Gunaydin","year":"2018","unstructured":"Gunaydin C, Bilge SS (2018) Effects of nonsteroidal anti-inflammatory drugs at the molecular level. Eurasian J Med 50:116\u2013121","journal-title":"Eurasian J Med"},{"key":"24_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ihj.2020.05.012","volume":"72","author":"R Pranata","year":"2020","unstructured":"Pranata R, Yonas E, Vania R, Prakoso R (2020) The efficacy and safety of oral paracetamol versus oral ibuprofen for patent ductus arteriosus closure in preterm neonates\u2014a systematic review and meta-analysis. Indian Heart J 72:151\u2013159. https:\/\/doi.org\/10.1016\/j.ihj.2020.05.012","journal-title":"Indian Heart J"},{"key":"24_CR31","doi-asserted-by":"publisher","unstructured":"Pereva S, Sarafska T, Bogdanova S, Spassov T (2016) Efficiency of \u201ccyclodextrin-ibuprofen\u201d inclusion complex formation. J Drug Deliv Sci Technol 35:34\u201339. https:\/\/doi.org\/10.1016\/j.jddst.2016.04.006","DOI":"10.1016\/j.jddst.2016.04.006"},{"key":"24_CR32","doi-asserted-by":"publisher","unstructured":"Thi Thanh Binh N, Thi Quynh Xuan H, Thi Hai Yen N (2020) Preparation and Characterization of\u2002Flurbiprofen\/\u03b2-Cyclodextrin Inclusion Complex. VNU Journal of Science: Medical and Pharma-ceutical Sciences 36:(3):40\u201348. https:\/\/doi.org\/10.25073\/2588-1132\/vnumps.4259","DOI":"10.25073\/2588-1132\/vnumps.4259"},{"key":"24_CR33","doi-asserted-by":"publisher","unstructured":"Vasincu IM, Apotrosoaei M, Lupascu F et al (2023) Complexes of ibuprofen thiazolidin-4-one derivatives with \u03b2-cyclodextrin: characterization and in vivo release profile and biological evaluation. Pharmaceutics 15:(10):2492. https:\/\/doi.org\/10.3390\/pharmaceutics15102492","DOI":"10.3390\/pharmaceutics15102492"},{"key":"24_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ijpharm.2018.04.007","volume":"543","author":"P Sengupta","year":"2018","unstructured":"Sengupta P, Chatterjee B, Tekade RK (2018) Current regulatory requirements and practical approaches for stability analysis of pharmaceutical products: A comprehensive review. Int J Pharm 543:328\u2013344","journal-title":"Int J Pharm"},{"key":"24_CR35","doi-asserted-by":"publisher","unstructured":"Swayze EE, Jefferson EA, Sannes-Lowery KA et al (2002) SAR by MS: A ligand based technique for drug lead discovery against structured RNA targets. J Med Chem 45:(18):3816\u20133819. https:\/\/doi.org\/10.1021\/jm0255466","DOI":"10.1021\/jm0255466"},{"key":"24_CR36","doi-asserted-by":"publisher","unstructured":"Camperi J, Grunert I, Heinrich K et al (2021) Inter-laboratory study to evaluate the performance of automated online characterization of antibody charge variants by multi-dimensional LC-MS\/MS. Talanta 234:122628. https:\/\/doi.org\/10.1016\/j.talanta.2021.122628","DOI":"10.1016\/j.talanta.2021.122628"},{"key":"24_CR37","doi-asserted-by":"publisher","unstructured":"Jones J, Pack L, Hunter JH, Valliere-Douglass JF (2020) Native size-exclusion chromatography-mass spectrometry: suitability for antibody\u2013drug conjugate drug-to-antibody ratio quantitation across a range of chemotypes and drug-loading levels. MAbs 12:(1):1682895. https:\/\/doi.org\/10.1080\/19420862.2019.1682895","DOI":"10.1080\/19420862.2019.1682895"},{"key":"24_CR38","unstructured":"Tank P, Vora S, D\u2019Souza F et al (2025) Advanced mass spectrometry techniques for monitoring biopharmaceutical host cell proteins. Trends Biotechnol 12(1):1682895"},{"key":"24_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejpb.2023.08.008","volume":"191","author":"A Gervais","year":"2023","unstructured":"Gervais A, Dirksen EHC, Pohl T et al. (2023) Compliance and regulatory considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory. Eur J Pharmaceut Biopharmaceut 191:57\u201367. https:\/\/doi.org\/10.1016\/j.ejpb.2023.08.008","journal-title":"Eur J Pharmaceut Biopharmaceut"},{"issue":"3","key":"24_CR40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1021\/acsmeasuresciau.3c00060","volume":"4","author":"AG Beck","year":"2024","unstructured":"Beck AG, Muhoberac M, Randolph CE, et al. (2024) Recent developments in machine learning for mass spectrometry. ACS Measurement Science Au 4(3):233\u2013246.","journal-title":"ACS Measurement Science Au"},{"key":"24_CR41","doi-asserted-by":"crossref","unstructured":"Boiko DA, Ananikov VP (2014) Machine learning meets mass spectrometry: a focused perspective. In: Artificial intelligence in Catalysis (eds V.P. Ananikov and M.V. Polynski). https:\/\/doi.org\/10.1002\/9783527847068.ch02","DOI":"10.1002\/9783527847068.ch02"},{"issue":"5-6","key":"24_CR42","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1515\/psr-2024-0006","volume":"10","author":"SC Alaribe","year":"2025","unstructured":"Alaribe SC, Titilayo BE, Ikpatt UN, et al. (2025) Computational methods for advanced mass spectrometry \u2013 a review. Phys Sci Rev 10(5-6):589\u2013620. https:\/\/doi.org\/10.1515\/psr-2024-0006","journal-title":"Phys Sci Rev"},{"key":"24_CR43","doi-asserted-by":"crossref","unstructured":"Gieroba B, Kryska A, Sroka-Bartnicka A (2025) Type 2 diabetes mellitus\u2014conventional therapies and future perspectives in innovative treatment. Biochem Biophys Rep 42:102037","DOI":"10.1016\/j.bbrep.2025.102037"},{"key":"24_CR44","doi-asserted-by":"publisher","unstructured":"Zhou J, Kang X, Luo Y et al (2019) Glibenclamide-induced autophagy inhibits its insulin secretion-improving function in \u03b2 cells. Int J Endocrinol 2019:1265175. https:\/\/doi.org\/10.1155\/2019\/1265175","DOI":"10.1155\/2019\/1265175"},{"key":"24_CR45","doi-asserted-by":"publisher","unstructured":"Aboushouk AA, Saad HM, Rohiem AH, Gad El-Karim DRS (2024) New Insights on the potential therapeutic effects of glibenclamide and obeticholic acid against alloxan-induced diabetes mellitus in rat model. Int Immunopharmacol 143:(pt 2):113469. https:\/\/doi.org\/10.1016\/j.intimp.2024.113469","DOI":"10.1016\/j.intimp.2024.113469"},{"key":"24_CR46","doi-asserted-by":"crossref","unstructured":"Ravari SS, Talaei B, Gharib Z (2021) The effects of silymarin on type 2 diabetes mellitus: a systematic review and meta-analysis. Obes Med 26:100368","DOI":"10.1016\/j.obmed.2021.100368"},{"key":"24_CR47","doi-asserted-by":"crossref","unstructured":"MacDonald-Ramos K, Mich\u00e1n L, Mart\u00ednez-Ibarra A, Cerb\u00f3n M (2021) Silymarin is an ally against insulin resistance: a review. Ann Hepatol 23:100255","DOI":"10.1016\/j.aohep.2020.08.072"},{"key":"24_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.microc.2016.02.011","volume":"127","author":"CM Monz\u00f3n","year":"2016","unstructured":"Monz\u00f3n CM, Teglia CM, Delfino MR, Goicoechea HC (2016) Chemometric optimization and validation of a novel dispersive liquid-liquid microextraction-HPLC method for gliclazide, glibenclamide and glimepiride quantitation in serum samples. Microchem J 127:113\u2013119. https:\/\/doi.org\/10.1016\/j.microc.2016.02.011","journal-title":"Microchem J"},{"key":"24_CR49","first-page":"119","volume":"34","author":"A Yusuf","year":"2009","unstructured":"Yusuf A, Hammami MM, Plazmas\u0131ndaki \u0130, et al. (2009) Validation of a new high performance liquid chromatography assay for glibenclamide in human plasma. FABAD J Pharm Sci 34:119\u2013125.","journal-title":"FABAD J Pharm Sci"},{"issue":"3-4","key":"24_CR50","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0731-7085(02)00013-4","volume":"28","author":"I Niopas","year":"2002","unstructured":"Niopas I, Daftsios AC (2002) A validated high-performance liquid chromatographic method for the determination of glibenclamide in human plasma and its application to pharmacokinetic studies. J Pharm Biomed Anal 28(3-4):653\u2013657. https:\/\/doi.org\/10.1016\/S0731-7085(02)00013-4","journal-title":"J Pharm Biomed Anal"},{"key":"24_CR51","doi-asserted-by":"publisher","unstructured":"Lai EPC, Feng SY (2006) Solid phase extraction-non-aqueous capillary electrophoresis for determination of metformin, phenformin and glyburide in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 843:(1):94\u201399. https:\/\/doi.org\/10.1016\/j.jchromb.2006.05.030","DOI":"10.1016\/j.jchromb.2006.05.030"},{"key":"24_CR52","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/bmc.635","volume":"20","author":"P Venkatesh","year":"2006","unstructured":"Venkatesh P, Harisudhan T, Choudhury H et al. (2006) Simultaneous estimation of six anti-diabetic drugs - Glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide and rosiglitazone: Development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human plasma assay. Biomed Chromatogr 20:1043\u20131048. https:\/\/doi.org\/10.1002\/bmc.635","journal-title":"Biomed Chromatogr"},{"key":"24_CR53","doi-asserted-by":"publisher","unstructured":"Liu H, Du Z, Yuan Q (2009) A novel rapid method for simultaneous determination of eight active compounds in silymarin using a reversed-phase UPLC-UV detector. J Chromatogr B Analyt Technol Biomed Life Sci 877(32):4159\u20134163. https:\/\/doi.org\/10.1016\/j.jchromb.2009.11.001","DOI":"10.1016\/j.jchromb.2009.11.001"},{"key":"24_CR54","doi-asserted-by":"publisher","unstructured":"Ha ES, Han DG, Seo SW et al (2019) A simple HPLC method for the quantitative determination of silybin in rat plasma: application to a comparative pharmacokinetic study on commercial silymarin products. Molecules 24(11):2180. https:\/\/doi.org\/10.3390\/molecules24112180","DOI":"10.3390\/molecules24112180"},{"key":"24_CR55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jchromb.2004.12.018","volume":"817","author":"S AbuRuz","year":"2005","unstructured":"AbuRuz S, Millership J, McElnay J (2005) The development and validation of liquid chromatography method for the simultaneous determination of metformin and glipizide, gliclazide, glibenclamide or glimperide in plasma. J Chromatogr B Analyt Technol Biomed Life Sci 817:277\u2013286. https:\/\/doi.org\/10.1016\/j.jchromb.2004.12.018","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"2","key":"24_CR56","first-page":"201","volume":"4","author":"J Khatri","year":"2001","unstructured":"Khatri J, Qassim S, Abed O, et al. (2001) A novel extractionless HPLC fluorescence method for the determination of glyburide in the human plasma: application to a bioequivalence study. J Pharm Pharm Sci 4(2):201\u2013206.","journal-title":"J Pharm Pharm Sci"},{"key":"24_CR57","doi-asserted-by":"publisher","unstructured":"Chen BM, Liang YZ, Guo FQ et al (2004) Rapid, simple, specific liquid chromatographic-electrospray mass spectrometry method for the determination of glibenclamide in human plasma. Anal Chim Acta 514(2):185\u2013191. https:\/\/doi.org\/10.1016\/j.aca.2004.03.044","DOI":"10.1016\/j.aca.2004.03.044"},{"key":"24_CR58","doi-asserted-by":"publisher","unstructured":"Li N, Deng Y, Wang D et al (2013) Determination of glibenclamide and puerarin in rat plasma by UPLC-MS\/MS: application to their pharmacokinetic interaction study. Talanta 104:109\u201315. https:\/\/doi.org\/10.1016\/j.talanta.2012.11.037","DOI":"10.1016\/j.talanta.2012.11.037"},{"key":"24_CR59","doi-asserted-by":"publisher","unstructured":"Alam MA, Al-Jenoobi FI, Al-Mohizea AM (2018) Rapid, validated UPLC-MS\/MS method for determination of glibenclamide in rat plasma. Int J Anal Chem 2018:2569027. https:\/\/doi.org\/10.1155\/2018\/2569027","DOI":"10.1155\/2018\/2569027"},{"key":"24_CR60","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jchromb.2007.04.032","volume":"854","author":"C Georgita","year":"2007","unstructured":"Georgita C, Albu F, David V, Medvedovici A (2007) Simultaneous assay of metformin and glibenclamide in human plasma based on extraction-less sample preparation procedure and LC\/(APCI)MS. J Chromatogr B Analyt Technol Biomed Life Sci 854:211\u2013218. https:\/\/doi.org\/10.1016\/j.jchromb.2007.04.032","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"24_CR61","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/bmc.2830","volume":"27","author":"S Ravindran","year":"2013","unstructured":"Ravindran S, Basu S, Gorti SKK et al. (2013) Metabolic profile of glyburide in human liver microsomes using LC-DAD-Q-TRAP-MS\/MS. Biomed Chromatogr 27:575\u2013582. https:\/\/doi.org\/10.1002\/bmc.2830","journal-title":"Biomed Chromatogr"},{"key":"24_CR62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jpba.2007.06.003","volume":"45","author":"HN Mistri","year":"2007","unstructured":"Mistri HN, Jangid AG, Shrivastav PS (2007) Liquid chromatography tandem mass spectrometry method for simultaneous determination of antidiabetic drugs metformin and glyburide in human plasma. J Pharm Biomed Anal 45:97\u2013106. https:\/\/doi.org\/10.1016\/j.jpba.2007.06.003","journal-title":"J Pharm Biomed Anal"},{"key":"24_CR63","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jchromb.2006.09.005","volume":"846","author":"F Albu","year":"2007","unstructured":"Albu F, Georgi C, David V, Medvedovici A (2007) Determination of glibenclamide in human plasma by liquid chromatography and atmospheric pressure chemical ionization\/MS-MS detection. J Chromatogr B Analyt Technol Biomed Life Sci 846:222\u2013229. https:\/\/doi.org\/10.1016\/j.jchromb.2006.09.005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"24_CR64","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1373\/clinchem.2005.050864","volume":"51","author":"G Hoizey","year":"2005","unstructured":"Hoizey G, Lamiable D, Trenque T et al. (2005) Identification and quantification of 8 sulfonylureas with clinical toxicology interest by liquid chromatography-ion-trap tandem mass spectrometry and library searching. Clin Chem 51:1666\u20131672. https:\/\/doi.org\/10.1373\/clinchem.2005.050864","journal-title":"Clin Chem"},{"key":"24_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchromb.2012.06.003","volume":"902","author":"BJ Brinda","year":"2012","unstructured":"Brinda BJ, Zhu HJ, Markowitz JS (2012) A sensitive LC-MS\/MS assay for the simultaneous analysis of the major active components of silymarin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 902:1\u20139. https:\/\/doi.org\/10.1016\/j.jchromb.2012.06.003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"24_CR66","doi-asserted-by":"publisher","unstructured":"Graf TN, Cech NB, Polyak SJ, Oberlies NH (2016) A validated UHPLC-tandem mass spectrometry method for quantitative analysis of flavonolignans in milk thistle (Silybum marianum) extracts. J Pharm Biomed Anal 126:26\u201333. https:\/\/doi.org\/10.1016\/j.jpba.2016.04.028","DOI":"10.1016\/j.jpba.2016.04.028"},{"key":"24_CR67","doi-asserted-by":"publisher","unstructured":"Lazzeroni M, Petrangolini G, Legarreta Iriberri JA et al (2020) Development of an HPLC-MS\/MS method for the determination of silybin in human plasma, urine and breast tissue. Molecules 25(12):2918. https:\/\/doi.org\/10.3390\/molecules25122918","DOI":"10.3390\/molecules25122918"},{"key":"24_CR68","doi-asserted-by":"publisher","unstructured":"Muchiri RN, van Breemen RB (2024) Chemical standardization of milk thistle (Silybum marianum L.) extract using UHPLC-MS\/MS and the method of standard addition. J Am Soc Mass Spectrom 35(8):1726\u20131732.\u2002https:\/\/doi.org\/10.1021\/jasms.4c00125","DOI":"10.1021\/jasms.4c00125"},{"key":"24_CR69","doi-asserted-by":"publisher","unstructured":"Condurache MI, Petrovici AR, Simionescu N et al (2022) Simultaneous determination of glibenclamide and silymarin released from Chitosan microparticles by HPLC-ESI-MS technique: method development and validation. Pharmaceutics 14(10):2164. https:\/\/doi.org\/10.3390\/pharmaceutics14102164","DOI":"10.3390\/pharmaceutics14102164"},{"key":"24_CR70","doi-asserted-by":"crossref","unstructured":"Aranaz I, Alc\u00e1ntara AR, Civera MC, et al (2021) Chitosan: an overview of its properties and applications. Polymers (Basel) 13(19):3256","DOI":"10.3390\/polym13193256"},{"key":"24_CR71","doi-asserted-by":"publisher","unstructured":"Porwal PK, Talele GS (2017) Development of validated HPLC-UV method for simultaneous determination of metformin, amlodipine, glibenclamide and atorvastatin in human plasma and application to protein binding studies. Bulletin of Faculty of Pharmacy, Cairo University 55(1):129\u2013139. https:\/\/doi.org\/10.1016\/j.bfopcu.2016.10.002","DOI":"10.1016\/j.bfopcu.2016.10.002"},{"key":"24_CR72","doi-asserted-by":"publisher","unstructured":"Korany MA, Haggag RS, Ragab MAA, Elmallah OA (2017) A validated stability-indicating HPLC method for simultaneous determination of Silymarin and Curcumin in various dosage forms. Arab J Chem 10(2_suppl):S1711\u2013S1725. https:\/\/doi.org\/10.1016\/j.arabjc.2013.06.021","DOI":"10.1016\/j.arabjc.2013.06.021"},{"key":"24_CR73","doi-asserted-by":"publisher","unstructured":"Confederat LG, Motrescu I, Condurache MI et al (2020) Chitosan-based delivery systems loaded with glibenclamide and lipoic acid: Formulation, characterization, and kinetic release studies. Applied Sciences (Switzerland) 10(21):7532. https:\/\/doi.org\/10.3390\/app10217532","DOI":"10.3390\/app10217532"},{"key":"24_CR74","doi-asserted-by":"publisher","unstructured":"Constantin SM, Buron F, Routier S et al (2019) Formulation and characterization of new polymeric systems based on chitosan and xanthine derivatives with thiazolidin-4-one scaffold. Materials 12(4):558. https:\/\/doi.org\/10.3390\/ma12040558","DOI":"10.3390\/ma12040558"},{"key":"24_CR75","doi-asserted-by":"publisher","unstructured":"Di Vito A, Chiarella E, Baudi F et al (2020) Dose-dependent effects of zoledronic acid on human periodontal ligament stem cells: an in vitro pilot study. Cell Transplant 29:963689720948497. https:\/\/doi.org\/10.1177\/0963689720948497","DOI":"10.1177\/0963689720948497"},{"key":"24_CR76","doi-asserted-by":"crossref","unstructured":"Munoz MA, Fletcher EK, Skinner OP et al (2021) Bisphosphonate drugs have actions in the lung and inhibit the mevalonate pathway in alveolar macrophages. Elife 10:e72430. https:\/\/doi.org\/10.7554\/eLife.72430","DOI":"10.7554\/eLife.72430"},{"key":"24_CR77","doi-asserted-by":"publisher","unstructured":"Rao BM, Srinivasu MK, Rani CP et al (2005) A validated stability indicating ion-pair RP-LC method for zoledronic acid. J Pharm Biomed Anal 39(3\u20134):781\u2013790. https:\/\/doi.org\/10.1016\/j.jpba.2005.04.012","DOI":"10.1016\/j.jpba.2005.04.012"},{"key":"24_CR78","doi-asserted-by":"publisher","unstructured":"Veldboer K, Vielhaber T, Ahrens H et al (2011) Determination of zoledronic acid in human urine and blood plasma using liquid chromatography\/electrospray mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 879(22):2073\u20132080. https:\/\/doi.org\/10.1016\/j.jchromb.2011.05.037","DOI":"10.1016\/j.jchromb.2011.05.037"},{"key":"24_CR79","doi-asserted-by":"publisher","unstructured":"Legay F, Gauron S, Deckert F et al (2002) Development and validation of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine. J Pharm Biomed Anal 30(4):897\u2013911. https:\/\/doi.org\/10.1016\/S0731-7085(02)00218-2","DOI":"10.1016\/S0731-7085(02)00218-2"},{"key":"24_CR80","doi-asserted-by":"publisher","unstructured":"Lo Faro AF, Giorgetti R, Busard\u00f2 FP et al (2019) Development and validation of a method using ultra performance liquid chromatography coupled to tandem mass spectrometry for determination of zoledronic acid concentration in human bone. J Pharm Biomed Anal 162:286\u2013290. https:\/\/doi.org\/10.1016\/j.jpba.2018.09.042","DOI":"10.1016\/j.jpba.2018.09.042"},{"key":"24_CR81","doi-asserted-by":"publisher","unstructured":"Mostefa Side Larbi MA, Sauzet C, Piccerelle P et al (2016) Thermodynamic study of the interaction between calcium and zoledronic acid by calorimetry. J Chem Thermodyn 97:290\u2013296. https:\/\/doi.org\/10.1016\/j.jct.2016.02.005","DOI":"10.1016\/j.jct.2016.02.005"},{"key":"24_CR82","doi-asserted-by":"publisher","unstructured":"Bayraktar D, Tas AC (1999) Chemical preparation of carbonated calcium hydroxyapatite powders at 37\u00b0C in urea-containing synthetic body fluids. J Eur Ceram Soc 19:2573\u20132579. https:\/\/doi.org\/10.1016\/s0955-2219(99)00132-6","DOI":"10.1016\/s0955-2219(99)00132-6"},{"key":"24_CR83","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5001\/omj.2010.49","volume":"25","author":"R Bushra","year":"2010","unstructured":"Bushra R, Aslam N (2010) An overview of clinical pharmacology of ibuprofen. Oman Med J 25:155\u2013161","journal-title":"Oman Med J"},{"key":"24_CR84","doi-asserted-by":"publisher","unstructured":"Abraham P, Indirani K, Desigamani K (2005) Nitro-arginine methyl ester, a non-selective inhibitor of nitric oxide synthase reduces ibuprofen-induced gastric mucosal injury in the rat. Dig Dis Sci\u200250(9):1632\u20131640.\u2002https:\/\/doi.org\/10.1007\/s10620-005-2908-y","DOI":"10.1007\/s10620-005-2908-y"},{"key":"24_CR85","doi-asserted-by":"publisher","unstructured":"Denizkusu S, Sabuncu E, Sipahi H, Avci D (2024) New ibuprofen cystamine salts with improved solubility and anti-inflammatory effect. ChemistryOpen 13(12):e202400206.\u2002https:\/\/doi.org\/10.1002\/open.202400206","DOI":"10.1002\/open.202400206"},{"key":"24_CR86","doi-asserted-by":"publisher","first-page":"12518","DOI":"10.1039\/d3ra01385e","volume":"13","author":"NZ Shah","year":"2023","unstructured":"Shah NZ, Avula SK, Karim N et al. (2023) Bio-oriented synthesis of ibuprofen derivatives for enhancement efficacy in post-operative and chronic inflammatory pain models. RSC Adv 13:12518\u201312528. https:\/\/doi.org\/10.1039\/d3ra01385e","journal-title":"RSC Adv"},{"key":"24_CR87","doi-asserted-by":"publisher","unstructured":"Shi Q, Jia Y, Wang H et al (2021) Identification of four ene reductases and their preliminary exploration in the asymmetric synthesis of (R)-dihydrocarvone and (R)-profen derivatives. Enzyme Microb Technol 150:109880. https:\/\/doi.org\/10.1016\/j.enzmictec.2021.109880","DOI":"10.1016\/j.enzmictec.2021.109880"},{"key":"24_CR88","doi-asserted-by":"publisher","unstructured":"Abbas AM, Aboelmagd A, Kishk SM et al (2022) A novel ibuprofen derivative and its complexes: physicochemical characterization, DFT modeling, docking, in vitro anti-inflammatory studies, and DNA interaction. Molecules 27(21):7540. https:\/\/doi.org\/10.3390\/molecules27217540","DOI":"10.3390\/molecules27217540"},{"key":"24_CR89","doi-asserted-by":"publisher","unstructured":"Madhavi K, Devi BK (2025) Synthetic strategies for the development of ibuprofen derivatives: a classified study. Curr Top Med Chem 25(10):1185\u20131216. https:\/\/doi.org\/10.2174\/0115680266334717241127043711","DOI":"10.2174\/0115680266334717241127043711"},{"key":"24_CR90","doi-asserted-by":"publisher","unstructured":"Sandilya AA, Natarajan U, Priya MH (2020) Molecular view into the cyclodextrin cavity: structure and hydration. ACS Omega 5(40):25655\u201325667. https:\/\/doi.org\/10.1021\/acsomega.0c02760","DOI":"10.1021\/acsomega.0c02760"},{"key":"24_CR91","doi-asserted-by":"crossref","unstructured":"Sharma N, Baldi A (2016) Exploring versatile applications of cyclodextrins: an overview. Drug Deliv 23(3):729\u2013747","DOI":"10.3109\/10717544.2014.938839"},{"key":"24_CR92","doi-asserted-by":"publisher","unstructured":"Raffaini G, Ganazzoli F (2020) Understanding surface interaction and inclusion complexes between piroxicam and native or crosslinked \u03b2-cyclodextrins: the role of drug concentration. molecules 25(12):2848. https:\/\/doi.org\/10.3390\/molecules25122848","DOI":"10.3390\/molecules25122848"},{"key":"24_CR93","doi-asserted-by":"publisher","unstructured":"Marangoci N, Timpu D, Corciova A et al (2019) \u03b2-cyclodextrin as a functional excipient used for enhancing the diminazene aceturate bioavailability. Pharmaceutics 11(6):295. https:\/\/doi.org\/10.3390\/pharmaceutics11060295","DOI":"10.3390\/pharmaceutics11060295"},{"key":"24_CR94","doi-asserted-by":"publisher","unstructured":"Heydari S, Kakhki RM (2017) Thermodynamic study of complex formation of \u03b2-cyclodextrin with ibuprofen by conductometric method and determination of ibuprofen in pharmaceutical drugs. Arab J Chem 10(1_suppl):S1223\u2013S1226. https:\/\/doi.org\/10.1016\/j.arabjc.2013.02.021","DOI":"10.1016\/j.arabjc.2013.02.021"},{"key":"24_CR95","doi-asserted-by":"publisher","unstructured":"\u0160kv\u00e1ra J, Nezbeda I (2018) Molecular dynamics study of racemic mixtures: Solutions of ibuprofen and \u03b2-cyclodextrin in methanol. J Mol Liq 265:791\u2013796. https:\/\/doi.org\/10.1016\/j.molliq.2018.07.020","DOI":"10.1016\/j.molliq.2018.07.020"},{"key":"24_CR96","doi-asserted-by":"publisher","unstructured":"Pereva S, Nikolova V, Sarafska T et al (2020) Inclusion complexes of ibuprofen and \u03b2-cyclodextrin: Supramolecular structure and stability. J Mol Struct 1205:127575. https:\/\/doi.org\/10.1016\/j.molstruc.2019.127575","DOI":"10.1016\/j.molstruc.2019.127575"},{"key":"24_CR97","doi-asserted-by":"publisher","unstructured":"Sarafska T, Ivanova S, Dudev T et al (2024) Enhanced Solubility of ibuprofen by complexation with \u03b2-cyclodextrin and citric acid. Molecules 29(7):1650. https:\/\/doi.org\/10.3390\/molecules29071650","DOI":"10.3390\/molecules29071650"},{"key":"24_CR98","doi-asserted-by":"publisher","unstructured":"Motzwickler-N\u00e9meth A, K\u00f6rmendi E, Farkas \u00c1 et al (2025) Nano-spray-drying of cyclodextrin\/ibuprofen complexes with aerosolization-enhancing additives for pulmonary drug delivery. Int J Mol Sci 26(9):4320. https:\/\/doi.org\/10.3390\/ijms26094320","DOI":"10.3390\/ijms26094320"},{"key":"24_CR99","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jchromb.2003.08.031","volume":"796","author":"PS Bonato","year":"2003","unstructured":"Bonato PS, Del Lama MPFM, De Carvalho R (2003) Enantioselective determination of ibuprofen in plasma by high-performance liquid chromatography-electrospray mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 796:413\u2013420. https:\/\/doi.org\/10.1016\/j.jchromb.2003.08.031","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"24_CR100","doi-asserted-by":"publisher","unstructured":"Naidong W, Lee JW (1994) Development and validation of a liquid chromatographic method for the quantitation of ibuprofen enantiomers in human plasma. J Pharm Biomed Anal 12(4):551\u2013556. https:\/\/doi.org\/10.1016\/0731-7085(94)80033-2","DOI":"10.1016\/0731-7085(94)80033-2"},{"key":"24_CR101","doi-asserted-by":"publisher","unstructured":"Menzel-Soglowek S, Geisslinger G, Brune K (1990) Stereoselective high-performance liquid chromatographic determination of ketoprofen, ibuprofen and fenoprofen in plasma using a chiral \u03b11-acid glycoprotein column. J Chromatogr B Biomed Sci Appl 532(2):295\u2013303. https:\/\/doi.org\/10.1016\/S0378-4347(00)83780-9","DOI":"10.1016\/S0378-4347(00)83780-9"},{"key":"24_CR102","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jchromb.2015.04.029","volume":"992","author":"N Nakov","year":"2015","unstructured":"Nakov N, Petkovska R, Ugrinova L et al. (2015) Critical development by design of a rugged HPLC-MS\/MS method for direct determination of ibuprofen enantiomers in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 992:67\u201375. https:\/\/doi.org\/10.1016\/j.jchromb.2015.04.029","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"24_CR103","doi-asserted-by":"crossref","unstructured":"Bhushan R, Martens J (1998) Resolution of enantiomers of ibuprofen by liquid chromatography: a review. Biomedical Chromatography 12(6):309\u2013316","DOI":"10.1002\/(SICI)1099-0801(199811\/12)12:6<309::AID-BMC763>3.0.CO;2-K"},{"key":"24_CR104","doi-asserted-by":"publisher","unstructured":"Lemko CH, Caill\u00e9 G, Foster RT (1993) Stereospecific high-performance liquid chromatographic assay of ibuprofen: improved sensitivity and sample processing efficiency. J Chromatogr B Biomed Sci Appl 619(2):330\u2013335. https:\/\/doi.org\/10.1016\/0378-4347(93)80126-O","DOI":"10.1016\/0378-4347(93)80126-O"},{"key":"24_CR105","doi-asserted-by":"publisher","unstructured":"Mendes GD, Mendes FD, Domingues CC et al (2008) Comparative bioavailability of three ibuprofen formulations in healthy human volunteers. Int J Clin Pharmacol Ther 46(6):309\u201318. https:\/\/doi.org\/10.5414\/CPP46309","DOI":"10.5414\/CPP46309"},{"key":"24_CR106","doi-asserted-by":"publisher","unstructured":"Teng XW, Wang SWJ, Davies NM (2003) Stereospecific high-performance liquid chromatographic analysis of ibuprofen in rat serum. J Chromatogr B Analyt Technol Biomed Life Sci 796(2):225\u2013231. https:\/\/doi.org\/10.1016\/j.jchromb.2003.07.010","DOI":"10.1016\/j.jchromb.2003.07.010"}],"container-title":["Advances in Experimental Medicine and Biology","Advancements of Mass Spectrometry in Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-29437-1_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:53:39Z","timestamp":1792601619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/chapter\/10.1007\/978-3-032-29437-1_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032294364","9783032294371"],"references-count":106,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-29437-1_24","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"23 January 2027","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}